Related Experiment Video
Updated: Sep 1, 2025
05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
22.0K
IV tenecteplase: A non-inferior alternative to alteplase?
Adeel S Zubair1, Kevin N Sheth2
1Department of Neurology, Yale School of Medicine, New Haven, CT, USA.
Med (New York, N.Y.)
|August 13, 2022
Abstract:
The standard medical therapy for intravenous thrombolysis in patients with stroke presenting within 3 h is alteplase, a tissue plasminogen activator. Menon and colleagues assessed the non-inferiority, efficacy, and safety of tenecteplase, a modified version of alteplase, in patients with acute ischemic stroke presenting within 4.5 h of onset.
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
67
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
67
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
867
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
867